The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2021

Filed:

Feb. 06, 2017
Applicants:

Beijing Biostar Technologies Ltd., Beijing, CN;

Chengdu Biostar Pharmaceuticals, Ltd., Sichuan, CN;

Inventors:

Li Tang, Beijing, CN;

Rongguo Qiu, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61K 47/40 (2006.01); A61K 47/44 (2017.01); A61K 47/34 (2017.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 31/7068 (2006.01); A61K 47/10 (2017.01); A61K 9/19 (2006.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61K 9/0019 (2013.01); A61K 31/7068 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); A61K 47/40 (2013.01); A61K 47/44 (2013.01); A61P 35/00 (2018.01); A61K 9/0053 (2013.01); A61K 9/19 (2013.01);
Abstract

The present application discloses a pharmaceutical preparation comprising a de-epoxidized epothilone derivative, and especially relates to a preparation formulation of a compound with reduced allergens and toxicity; and also relates to the use thereof in the treatment of tumours, especially the use thereof in the treatment of solid tumours that are resistant to and fail to respond to other conventional chemotherapeutic agents, as well as the use thereof in the treatment of cancers alone or in combination with other tumour drugs or auxiliary drugs.


Find Patent Forward Citations

Loading…